Cutting edge: A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses

Journal of Immunology

Volumn 167, Issue 10, 2001, Pages 5531-5534

  Exley, M A ^a   Tahir, S M A ^a   Cheng, O ^a   Shaulov, A ^a   Joyce, R ^a   Avigan, D ^a   Sackstein, R ^a   Balk, S P ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; CD161 ANTIGEN; CD1D ANTIGEN; CYTOKINE; LECTIN; MEMBRANE ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOID CELL; MIXED LYMPHOCYTE REACTION; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CELL LINE; CLASSIFICATION; HELA CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIXED LYMPHOCYTE CULTURE;

ANTIGENS, CD1; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL LINE; CELLS, CULTURED; CYTOKINES; HELA CELLS; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE CULTURE TEST, MIXED; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 0035889883     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.10.5531     Document Type: Article

References (36)

1. + T cells: A new T cell subset
2. Mouse CD1d-specific NK1 T cells: Development, specificity, and function
3. Recognition and function of Vα14 NKT cells
4. + T lymphocytes
5. - T cells
6. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
7. CD161 (NKR-PIA) co-stimulation of CD1d-dependent activation of human T cells expressing invariant Vα24 JαQ T cell receptor α chains
8. Human CD161A: A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
9. + targets
10. Diverse TCRs recognize murine CD1
11. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells
12. Distinct subsets of CD1d-restricted T cells recognize self-antigens in different cellular compartments
13. Heterogeneity of NK T cells in the bone marrow: Divergence from thymus
14. - NK T cells with distinct TCR αβ repertoires and differential distribution in lymphoid tissues
15. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
16. Differential tumor surveillance by natural killer (NK) and NKT cells
17. NKT cells/CD1 interactions required for development of anterior chamber induced immune deviation, but not intravenous tolerance
18. NKT cell activation inhibits HBV replication in vivo
19. Amelioration of encephalomyocarditis virus induced disease by activation of CD1d-reactive T cells
20. + T cells and rapid elimination of effector cells by apoptosis
21. + cell lines
22. + T cells reciprocally regulate acute graft-versus-host disease
23. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion
24. Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation
25. T-cell subsets and suppressor cells in human bone marrow
26. +) in the blood of normal donors
27. Prevention of graft-versus-host disease after BM transplantation
28. Allogeneic hematopoietic stem cell transplantation in recipients of cellular or solid organ allografts
29. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts
30. New strategies for bone marrow transplantation
31. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses
32. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells, and monocytes
33. Loss of IFN-γ production by invariant NK T cells in advanced cancer
34. Cross-talk between cells of the innate immune system: NK T cells rapidly activate NK cells
35. α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells
36. + killer cells